Nationality Australian, British Spouse Professor Paul Fine | Name Valerie Beral Role Epidemiologist | |
 | ||
Born 28 July 1946 (age 77)
Australia ( 1946-07-28 ) Institutions University of Oxford
London School of Hygiene and Tropical Medicine
Hammersmith Hospital Alma mater University of Sydney
London School of Hygiene and Tropical Medicine Known for Breast cancer epidemiology Notable awards Fellow of the Royal Society (2006)
Dame Commander of the Order of the British Empire (2010)
Companion of the Order of Australia (2010) Education London School of Hygiene & Tropical Medicine, University of Sydney Fields Epidemiology, Epidemiology of cancer, Breast cancer, Women's health | ||
Insights valerie beral
Dame Valerie Beral AC DBE FRS FRCOG FMedSci (born 1946) is an Australian-born British epidemiologist, academic and a preeminent specialist in breast cancer epidemiology. She is Professor of Epidemiology, a Fellow of Green Templeton College, Oxford and has been the Head of the Cancer Epidemiology Unit at the University of Oxford and Cancer Research UK since 1989.
Contents
- Insights valerie beral
- The million women study understanding women s health professor dame valerie beral
- Education and training
- Career
- Million Women Study
- Honours and awards
- Personal life
- References
The million women study understanding women s health professor dame valerie beral
Education and training
Valerie Beral was born in Australia on 28 July 1946. She completed her MBBS degree graduating with first-class honours from the University of Sydney in 1969.
She then spent six months travelling the "hippie trail" through Asia of which she said "That taught me how much I wanted to work. But I still wanted to leave Australia." She then travelled to England and successfully applied for a job at the Hammersmith Hospital.
Career
At Hammersmith Hospital, she worked under Charles Fletcher, who recognised that she was suited to epidemiology and so propelled her towards the London School of Hygiene and Tropical Medicine. There she completed a combined course in Epidemiology & Statistics in 1971–1972 under the tutorship of Donald Reid. Beral felt very comfortable with the move because she had never felt happy in clinical medicine. She says that "she had never been able to understand how her peers could be so certain about making decisions on incomplete evidence. Epidemiology has offered her not an escape from that uncertainty, but the opportunity to tackle it head on." She also became a member of the Royal College of Physicians.
One of Beral's first interests as a professional epidemiologist was the combined oral contraceptive pill because of work she had previously done in family planning. She felt that epidemiology would give her the tools to begin to answer the questions that people had asked her about safety of the pill. Although Beral has moved on to other projects, this is still one area in which the data have yet to provide support for her initial instinct that the contraceptive pill, like pregnancy, will eventually be shown to protect against breast cancer. Later work included the effects of radiation, breast cancer trials and screening, AIDS, gene therapy, Hiroshima survivors, Chernobyl, food toxins, and much else. The British Medical Journal described her tally of jobs, publications, and committees as reading "like a checklist of the epidemiological causes célebres of the past three decades".
Beral completed her training in 1972 and began working for the London School of Hygiene and Tropical Medicine for a number of years. From there she moved to direct the Cancer Research UK Cancer Epidemiology Unit at the University of Oxford in 1989. Beral said of being offered the role: "One of the major deterrents when I was offered the ICRF job in 1989 was the thought of being so much in the public eye. It's not my nature."
Beral has served on various international committees for the World Health Organisation and the United States National Academy of Sciences. She also chairs the Department of Health's Advisory Committee on Breast Cancer Screening.
Million Women Study
Beral was one of the leaders of the Million Women Study which was opened in 1997, and has recruited more than 1.3 million UK women over 50 via the NHS breast screening centres. The study is investigating how a woman's reproductive history can affect her health, with a particular focus on the effects of hormone replacement therapy (HRT). It is the largest such study in the world with one in four of UK women in the target age group participating.
In August 2003, Beral's group published results showing that taking HRT increases a woman's risk of developing breast cancer with an estimated 20,000 UK women aged 50–64 having possibly developed the disease between 1993 and 2003 due to HRT use. The study also showed that risk increases the longer a woman uses HRT, but drops to the normal level within five years after stopping use.
Honours and awards
Personal life
Beral's work is based in Oxford where she has a flat. She also spends time in her house in north London, shared with her American partner, Paul Fine, who works at the London School of Hygiene and Tropical Medicine. She maintains close links with her native Australia but "could not imagine returning to live there". Aside from concerns that Australia would hold little for her partner, Beral has also joked that "The population's too small!" to satisfy her needs as an epidemiologist.